Skip to main content
Table of Contents
Print

Can Cannabis Replace Benzodiazepines for OCD-Related Anxiety? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Exploring whether cannabis vs benzodiazepines for OCD could be a viable approach is increasingly relevant for patients seeking alternatives to traditional medications. Benzodiazepines are commonly used for anxiety but can carry risks of dependence and sedation. 

Understanding Anxiety Relief Options 

Research on cannabis vs benzodiazepines for OCD is growing, with interest in whether cannabinoids may offer similar calming effects without the drawbacks of long-term benzo use. 

Marijuana for Anxiety Relief in OCD 

Some patients find that marijuana for anxiety relief in OCD helps reduce intrusive thoughts and improve daily functioning, though responses can vary. 

Benzo Alternatives for OCD 

Exploring benzo alternatives for OCD is important for those who cannot tolerate or wish to avoid benzodiazepines due to side effects or dependency risks. 

Calming Treatments 

Investigating natural calming treatments such as cannabis can help patients find complementary or replacement therapies for managing anxiety symptoms. 

Clinical Considerations 

Working with a healthcare provider ensures that the transition from benzodiazepines to cannabis is safe and personalised, avoiding withdrawal complications. 

Overall, carefully guided use of cannabis vs benzodiazepines for OCD could offer relief while minimising the potential harms associated with long-term benzodiazepine use. 

If you’re exploring cannabis treatment options for obsessive-compulsive disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obsessive-Compulsive Disorder.

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories